Food and Drug Administration Drug Safety Podcast
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)
- Author: Podcast
- Narrator: Podcast
- Publisher: Podcast
- Duration: 0:03:30
- More information
Informações:
Synopsis
Listen to an audio podcast of the February 3, 2022, FDA Drug Safety Communication, FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). We are re-evaluating this risk against the benefits of Ukoniq for its approved uses.
